# Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/inhibition-of-sars-cov-2-previously-2019-ncov-infection-by-a-highly-potent-pan/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shuai Xia,Meiqin Liu,Chao Wang,Wei Xu,Qiaoshuai Lan,Siliang Feng,Feifei Qi,Linlin Bao,Lanying Du,Shuwen Liu,Chuan Qin,Fei Sun,Zhengli Shi,Yun Zhu,Shibo Jiang,Lu Lu |
| Citations | 1,446 |
| DOI | 10.1038/s41422-020-0305-x |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.nature.com/articles/s41422-020-0305-x.pdf |
| OpenAlex ID | https://openalex.org/W3013855790 |
| PMID | 32231345 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Feifei Qi](https://scholariq.org/researchers/feifei-qi/)

## Paper primary topic

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)

## Paper topics

- [SARS-CoV-2 and COVID-19 Research](https://scholariq.org/topics/sars-cov-2-and-covid-19-research/)
- [interferon and immune responses](https://scholariq.org/topics/interferon-and-immune-responses/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.